Table 1.
Baseline characteristics
Baseline characteristics | Group 1: Suture (n=119) | Group 2: Staple (n=107) | P-value |
---|---|---|---|
Age (mean ± SD) | 64.43±13.19 | 64.99±13.35 | 0.904 |
Male (%) | 81 (68.1%) | 70 (65.4%) | 0.673 |
BMI (mean ± SD) | 27.13±2.84 | 27.27±2.18 | 0.102 |
Coronary artery disease | 62 (52.1%) | 63 (58.9%) | 0.300 |
Ischemic cardiomyopathy | 47 (39.5%) | 48 (44.9%) | 0.417 |
Dilated cardiomyopathy | 48 (40.3%) | 27 (25.2%) | 0.018 |
Hypertensive heart disease | 14 (11.8%) | 20 (18.7%) | 0.143 |
Diabetes | 70 (58.8%) | 49 (41.2%) | 0.200 |
Hypertension | 55 (46.2%) | 41 (38.3%) | 0.238 |
CKD | 36 (30.3%) | 26 (24.3%) | 0.315 |
Smoking | 45 (37.8%) | 46 (43%) | 0.421 |
Ejection fraction (%) | 37.10±10.70 | 38.50±12.17 | 0.143 |
Aspirin | 42 (35.3%) | 54 (50.5%) | 0.029 |
Clopidogrel | 36 (30.3%) | 34 (31.8%) | 0.806 |
Aspirin plus clopidogrel | 24 (20.2%) | 33 (30.8%) | 0.061 |
Warfarin | 13 (10.9%) | 8 (7.5%) | 0.378 |
Rivaroxaban | 10 (8.4%) | 18 (16.8%) | 0.053 |
Triple anticoagulation | 3 (2.5%) | 5 (4.7%) | 0.381 |
SD - standard deviation; CKD - chronic kidney disease